Barrington Research Issues Pessimistic Forecast for Merit Medical Systems (NASDAQ:MMSI) Stock Price

Merit Medical Systems (NASDAQ:MMSI - Free Report) had its price objective decreased by Barrington Research from $111.00 to $103.00 in a research note released on Friday morning, Marketbeat Ratings reports. Barrington Research currently has an outperform rating on the medical instruments supplier's stock. Barrington Research also issued estimates for Merit Medical Systems' Q2 2025 earnings at $0.88 EPS, Q3 2025 earnings at $0.80 EPS, Q4 2025 earnings at $0.80 EPS, Q1 2026 earnings at $0.81 EPS, Q2 2026 earnings at $1.05 EPS, Q3 2026 earnings at $0.91 EPS, Q4 2026 earnings at $0.94 EPS and FY2027 earnings at $4.05 EPS.

A number of other brokerages have also weighed in on MMSI. Needham & Company LLC reiterated a "buy" rating and issued a $116.00 price objective on shares of Merit Medical Systems in a research report on Wednesday, April 9th. JPMorgan Chase & Co. began coverage on shares of Merit Medical Systems in a research report on Friday, March 28th. They set an "overweight" rating and a $120.00 price objective on the stock. Raymond James lifted their target price on shares of Merit Medical Systems from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Tuesday, December 31st. Wells Fargo & Company decreased their price target on shares of Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a research note on Wednesday, February 26th. Finally, Canaccord Genuity Group cut their price objective on Merit Medical Systems from $128.00 to $127.00 and set a "buy" rating on the stock in a research report on Wednesday, February 26th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Merit Medical Systems has an average rating of "Moderate Buy" and an average target price of $109.00.

Merit Medical Systems Trading Down 0.1 %

Shares of Merit Medical Systems stock traded down $0.06 during trading on Friday, reaching $94.61. 1,278,090 shares of the stock were exchanged, compared to its average volume of 497,926. Merit Medical Systems has a 1 year low of $73.67 and a 1 year high of $111.45. The firm has a market cap of $5.59 billion, a price-to-earnings ratio of 46.38, a price-to-earnings-growth ratio of 2.34 and a beta of 0.85. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. The stock's fifty day moving average is $98.60 and its 200 day moving average is $100.60.

Insider Activity at Merit Medical Systems

In related news, Director Stephen C. Evans sold 5,000 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $105.31, for a total transaction of $526,550.00. Following the sale, the director now directly owns 4,657 shares of the company's stock, valued at approximately $490,428.67. This represents a 51.78 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Brian G. Lloyd sold 25,000 shares of Merit Medical Systems stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the completion of the transaction, the insider now directly owns 38,993 shares of the company's stock, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 109,132 shares of company stock valued at $11,139,521 in the last 90 days. Corporate insiders own 3.70% of the company's stock.

Hedge Funds Weigh In On Merit Medical Systems

A number of hedge funds have recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Merit Medical Systems in the 4th quarter worth $66,638,000. Raymond James Financial Inc. purchased a new stake in shares of Merit Medical Systems during the 4th quarter valued at about $48,926,000. FMR LLC boosted its holdings in shares of Merit Medical Systems by 31.6% during the 4th quarter. FMR LLC now owns 2,076,439 shares of the medical instruments supplier's stock valued at $200,833,000 after acquiring an additional 499,193 shares during the last quarter. Groupama Asset Managment purchased a new position in shares of Merit Medical Systems during the fourth quarter valued at approximately $38,688,000. Finally, Bryn Mawr Capital Management LLC purchased a new stake in Merit Medical Systems in the fourth quarter worth approximately $36,057,000. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.